Firstly, BMSCs from patients with ankylosing spondylitis exhibit abnormal angiogenic capabilities; increased expression of the SMAD-specific E3 ubiquitin ligase Smurf2 in BMSCs is a primary cause of this anomaly. This evidence concerns the gene SMURF2 and ankylosing spondylitis.